Acacia, a publicly-traded investor, agreed to acquire stakes in 19 life science companies from LF Equity Income Fund for $290m. “This transaction is representative of the exceptional capabilities of Acacia’s transactional team with the financial and structuring support of our strategic partnership with Starboard Value LP. Despite pandemic conditions in the USA and UK, this transaction was enabled by the resources that Acacia brought to bear, including experience in complex financial structures; and highlights the flexibility and agility of our investment team – all supported by our ready access to capital,” Clifford Press, Acacia CEO.